Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized , Double-blind, Parallel, Placebo-controlled Design Clinical Trial of GW117 Tablets

NCT06796868 is registered in ClinicalTrials.gov with Beijing Greatway Pharmaceutical Technology Co.,Ltd. as lead sponsor.

NCT NCT06796868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06796868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized , Double-blind, Parallel, Placebo-controlled Design Clinical Trial of GW117 Tablets
Lead sponsor
Beijing Greatway Pharmaceutical Technology Co.,Ltd.
Phase
Phase 2
Overall status
Completed
Start date
July 7, 2022
Completion date
October 12, 2023
Enrollment
280 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder (mdd)